HeartSciences files Certificate of Designations for Series D Preferred Stock in $15M offering

HeartSciences Inc.

Designates 4,285,714 shares of Series D Convertible Preferred Stock for the Unit offering (each Unit: one Series D share + warrant to buy common at $5.00).
Each Series D share convertible into one common share at holder's option.
No dividends; perpetual, non-redeemable, ranks senior to common on liquidation rights.
Company may force conversion upon change in control, common stock ≥$5.00 for 10 days, or $15M underwritten offering.
Liquidation preference of $3.50 per share plus unpaid dividends before junior securities.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.